Extremely variable; relies on reaction to therapy and organ involvement.

Overall good with prompt diagnosis and suitable care.

A significant contributor to mortality risk is heart involvement.

Numerous patients can attain long-term remission.

Corticosteroids for the first control, such as prednisone.

Immunosuppressive medications (such as methotrexate and cyclophosphamide) for severe conditions.

Mepolizumab is one example of a biologic that targets IL-5 in patients who are resistant or relapse.

In extreme, life-threatening circumstances, plasmapheresis handling.

Care for concomitant illnesses (such as asthma and hypertension) and monitor for any problems.

Increased survival rates when intensive therapy is received early.

Possibility of a sustained remission for a sizable percentage of patients.

Relapse risk, which is frequently controllable with therapy modifications.

Some people have a chronic illness that requires constant care.

Long-term quality of life and prognosis can be affected by organ disease, particularly cardiac and renal impairment.

Side effects of prolonged immunosuppressive medication usage.